# Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region

> **NCT07566286** · NA · NOT_YET_RECRUITING · sponsor: **Galderma R&D** · enrollment: 100 (estimated)

## Conditions studied

- Chin Augmentation

## Interventions

- **DEVICE:** Restylane Lyft with Lidocaine

## Key facts

- **NCT ID:** NCT07566286
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-11-01
- **Final completion:** 2028-02-28
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07566286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07566286, "Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07566286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*